Saudi healthtech startup Madeed lands $925K to expand preventive care

Mohammed Kamal

Last updated 5-05-2026

3 min

Saudi healthtech startup Madeed raised $925,000 in a pre-seed funding round.

Funds will boost product development and expand its preventive platform nationwide.

The startup targets “personalised preventive healthcare” powered by AI and data.

Its model supports Vision 2030’s push for digitised, prevention-focused healthcare.

The deal reflects growing investor interest in chronic disease solutions.

Saudi healthtech startup Madeed has secured $925,000 in a pre-seed round, a move that should help the company expand its personalised preventive healthcare platform across Saudi Arabia. The capital is set to go into product development as well as wider market expansion inside the Kingdom.

The news lands at a time when Saudi Arabia’s healthtech space is getting real traction, with investors paying closer attention to startups trying to modernise care before people get seriously ill. Madeed’s focus is on preventive healthcare, which, in simple words, means helping people manage health risks early rather than waiting until treatment becomes a bigger and more expensive affair. I reckon that is where a lot of the real value sits, especially in markets dealing with rising chronic illness.

It also fits neatly with Saudi Arabia’s Vision 2030 agenda, which has put strong emphasis on digitising healthcare and making preventive medicine more central to the system. That bigger backdrop matters. Startups like Madeed are not just building apps and platforms for the sake of it; they are operating in a market where policy direction, healthcare demand and investor appetite are starting to line up rather well.

From what can be seen, the company is betting on personalisation powered by AI to address chronic disease management more effectively. That is a bit of a mouthful, well… I mean, the basic idea is using data and software to tailor healthcare guidance to each person instead of offering the same generic approach to everyone. In a region where diabetes, obesity and other long-term conditions continue to put pressure on health systems, that feels quite spot on.

For readers who follow startups on Arageek, this kind of story may sound familiar. I’ve often noticed that the most promising MENA founders are the ones trying to solve boring-but-important problems, not just chasing flashy trends. Preventive care is not always the loudest corner of tech, on the flip side it can have one of the biggest long-term impacts if the model works and scales. And believe it or not, that is exactly why investors are starting to pay attention.

More broadly, the raise adds to the early-stage funding momentum around MENA startups building tools for chronic disease prevention and management. Saudi Arabia, in particular, is turning into a key market for these ventures, helped by a policy push, a large population and growing interest in digital health. For an early startup, $925,000 is not endless money, of course, but it can definately give enough runway to sharpen the product and prove demand in a market that is moving fast.

🚀 Got exciting news to share?

If you're a startup founder, VC, or PR agency with big updates—funding rounds, product launches 📢, or company milestones 🎉 — AraGeek English wants to hear from you!